Sign in

Emilie Gunn

@emiliemgunn.bsky.social
145 followers 155 following 32 posts

Journals Director @ ASCO, President @ Council of Science Editors, mom, reader, cook, knitter, Girl Scouts leader, runner, general lover of words. All views are mine.

PostsRepliesMedia
Reposted by Emilie Gunn
JCO Journals @jco-asco.bsky.social · 23/10/2025
Publish with JCO GO or JCO OA. Advantages of fully #OpenAccess journals include: More citations & downloads Greater engagement A wider opportunity to advance cancer care globally Compliance with funder mandates With International #OAWeek coming up, learn how you can expand your reach.
011
Reposted by Emilie Gunn
JCO Journals @jco-asco.bsky.social · 31/10/2025
Check out the article in JCO on the Metformin Active Surveillance Trial in Low-Risk Prostate Cancer. Learn about the latest research on this common drug's potential role in managing prostate cancer: brnw.ch/21wX6DG
011
Emilie Gunn @emiliemgunn.bsky.social · 03/10/2025
@councilscienceed.bsky.social (CSE) is offering our virtual Short Course on Pub Management on 10/31/25. The agenda is full of everything you need to know to make your publication the best it can be. 15% off if you also reg for the CSE Fall Symposium! www.councilscienceeditors.org/short-courses
councilscienceeditors.org
Short Courses
000
Reposted by Emilie Gunn
JCO Journals @jco-asco.bsky.social · 19/09/2025
We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.
0117
Emilie Gunn @emiliemgunn.bsky.social · 20/08/2025
Now available!! 🎧 Listen in to JCO OP's latest podcast, Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications ascopubs.org/do/promoting...
ascopubs.org
Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications
An estimated 85k adolescents and young adults (AYAs) between the ages of 15 to 39 will be diagnosed with cancer in the United States this year. AYAs with advanced cancer face care gaps for psychosocia...
000
Emilie Gunn @emiliemgunn.bsky.social · 01/07/2025
Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries | JCO Global Oncology ascopubs.org/doi/10.1200/...
ascopubs.org
Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries | JCO Global Oncology
The growing cancer burden and suboptimal diagnostic capacity in low- and middle-income countries calls for urgent innovation in diagnostic solutions. Point-of-care technologies (POCTs) offer a transfo...
000
Emilie Gunn @emiliemgunn.bsky.social · 18/06/2025
Listen to the latest JCO Oncology Practice podcast, in which @fumikochino.bsky.social discusses barriers to cancer care that seem minor (e.g. paying for park) but are definitely not. ascopubs.org/do/park-park...
ascopubs.org
Park the Parking: Patient and Caregiver Perspectives on Transportation Barriers in Cancer | Podcast | ASCO Publications
Frustrations regarding the costs and difficulties with parking at hospitals is a common concern voiced by patients, families, and healthcare providers. Transportation barriers to receiving cancer care...
010
Emilie Gunn @emiliemgunn.bsky.social · 31/05/2025
Stay connected to JCO Journals during #ASCO25! www.asco.org/annual-meeti...
asco.org
JCO Central - ASCO
020
Reposted by Emilie Gunn
Kathy D Miller, MD @kathydmillermd.bsky.social · 31/05/2025
Stop by JCO central while at ASCO. Enjoy the coffee, meet the editors and staff, learn more about JCO
021
Emilie Gunn @emiliemgunn.bsky.social · 31/05/2025
Simultaneous Publication in #JCOOP. #ASCO25 Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice
PURPOSEMedical podcast integration into hematology/oncology fellowship curricula remains largely unstudied. We conducted a multicenter cluster randomized trial to evaluate the educational impact of a ...
031
Emilie Gunn @emiliemgunn.bsky.social · 31/05/2025
If you didn't hang out in JCO Central, did you even really attend #ASCO25? Come join us for some great events in S403b!
142
Reposted by Emilie Gunn
American Society of Clinical Oncology @ascocancer.bsky.social · 30/05/2025
‼️ #ASCO25 simultaneous publication by Jacobs et al:  BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
044
Emilie Gunn @emiliemgunn.bsky.social · 30/05/2025
Read all about it! Simultaneous Publication out now in JCO: BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
ascopubs.org
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation
PURPOSEFamily and friend caregivers of patients undergoing hematopoietic stem-cell transplantation (HSCT) struggle with immense caregiving burden, leading to substantial quality of life (QOL) impairme...
000
Reposted by Emilie Gunn
American Society of Clinical Oncology @ascocancer.bsky.social · 29/05/2025
Psst ... want to see how we're brewing up #ASCO25? We're busy behind the scenes making sure everything's just right! Can't WAIT to officially open the doors, welcome everyone, and get this Annual Meeting party started! See you there!
1318
Emilie Gunn @emiliemgunn.bsky.social · 23/05/2025
Pregnancy and Breast Cancer | Podcast | ASCO Publications ascopubs.org/do/pregnancy...
ascopubs.org
Pregnancy and Breast Cancer | Podcast | ASCO Publications
Dr. Chino talks with Dr. Erin Roesch and patient advocate Julia Maues about pregnancy associated cancer with a focus on breast cancer, the most common cancer diagnosed during pregnancy. This discussio...
000
Emilie Gunn @emiliemgunn.bsky.social · 22/05/2025
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change | JCO Oncology Practice
PURPOSEAs the complexity and need for cancer care services continue to grow, time to treatment initiation (TTI) has been increasing across cancer types. Presently there are no comprehensive analyses i...
000
Reposted by Emilie Gunn
Jeremy Warner, MD, MS, FAMIA, FASCO @hemoncwarner.bsky.social · 20/05/2025
Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....
ascopubs.org
ASCO Publications
113
Emilie Gunn @emiliemgunn.bsky.social · 28/04/2025
📣 Have something to report on an ongoing clinical trial? #JCOOA now accepting Trials in Progress articles! Read the first one here: SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...
ascopubs.org
SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low–Tumor Burden Follicular Lymphoma | JCO Oncology Advances
101
Emilie Gunn @emiliemgunn.bsky.social · 24/04/2025
In the latest episode of JCO OP: Put Into Practice, @fumikochino.bsky.social talks with Dr. Atif Khan and Dr. Lola Fayanju about treatment de-escalation in patients with breast cancer. ascopubs.org/do/treatment...
ascopubs.org
Treatment De-escalation for Favorable Risk Breast Cancer | Podcast | ASCO Publications
Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, sh...
010
Emilie Gunn @emiliemgunn.bsky.social · 11/04/2025
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice
PURPOSEThe purpose ot this study was to assess the effectiveness of an educational video compared to in-person genetic counseling for cancer genetic testing candidates. Genetic cancer risk assessment ...
011
Reposted by Emilie Gunn
Satan’s Niece @krissychula.bsky.social · 06/04/2025
This is high art
526263157517
Reposted by Emilie Gunn
Council of Science Editors @councilscienceed.bsky.social · 25/03/2025
Navigating a change from self-publishing, independent publishing, or a commercial publisher can be tenuous and fraught. Join Adam Etkin and Susan Willner at 12 PM ET as we discuss how to plan for an effective publisher move! Register NOW: www.councilscienceeditors.org/cse-connect
121
Emilie Gunn @emiliemgunn.bsky.social · 21/03/2025
Early Bird registration is ending soon for the @councilscienceed.bsky.social annual meeting. Join us in Minneapolis May 3-6!
023
Emilie Gunn @emiliemgunn.bsky.social · 21/03/2025
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations | JCO Clinical Cancer Informatics ascopubs.org/doi/10.1200/...
ascopubs.org
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations | JCO Clinical Cancer Informatics
PURPOSETo determine the accuracy of large language models (LLMs) in generating appropriate treatment options for patients with early breast cancer on the basis of their medical records.MATERIALS AND M...
000
Emilie Gunn @emiliemgunn.bsky.social · 20/03/2025
🎙️In the latest #JCOOP podcast, @fumikochino.bsky.social discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient burdens from prior auth. 🎧 ascopubs.org/do/prior-aut...
ascopubs.org
Prior Authorization: How Did We Get Here and Where Are We Going? | ASCO Publications
Dr. Chino discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient b...
064
Emilie Gunn @emiliemgunn.bsky.social · 18/03/2025
Phase II Evaluation of Ultra-Hypofractionated Postoperative Radiation Therapy for Breast Cancer: Toxicity and Efficacy in a Single-Center Nonrandomized Prospective Study | JCO Global Oncology ascopubs.org/doi/10.1200/...
ascopubs.org
Phase II Evaluation of Ultra-Hypofractionated Postoperative Radiation Therapy for Breast Cancer: Toxicity and Efficacy in a Single-Center Nonrandomized Prospective Study | JCO Global Oncology
PURPOSETo evaluate the toxicity profile and efficacy of postoperative ultra-hypofractionated radiation therapy in elderly patients with breast cancer.MATERIALS AND METHODSThis is a nonrandomized, sing...
000
Emilie Gunn @emiliemgunn.bsky.social · 13/03/2025
ICYMI: JCO Oncology Practice has a new podcast, and the second episode is here: ascopubs.org/do/optimizin... Subscribe wherever you get your podcasts! #JCOOP
ascopubs.org
Optimizing the Electronic Health Record for Patient-Centered Cancer Care | ASCO Publications
Dr. Chino talks with Dr. Aditi Singh and patient advocate Liz Salmi about how this essential tool for documentation could be optimized to be more patient-centered. This discussion will be based off th...
000
Emilie Gunn @emiliemgunn.bsky.social · 12/03/2025
Real-World Utilization and Performance of Circulating Tumor DNA Monitoring to Predict Recurrence in Solid Tumors | JCO Oncology Advances ascopubs.org/doi/10.1200/...
ascopubs.org
Real-World Utilization and Performance of Circulating Tumor DNA Monitoring to Predict Recurrence in Solid Tumors | JCO Oncology Advances
PURPOSECirculating tumor DNA (ctDNA) is a novel biomarker to monitor treatment response and predict cancer recurrence. However, the real-world performance of ctDNA monitoring is not well characterized...
010
Emilie Gunn @emiliemgunn.bsky.social · 10/03/2025
Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide | JCO Oncology Practice ascopubs.org/doi/10.1200/...
ascopubs.org
Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide | JCO Oncology Practice
Global incidence of hepatocellular carcinoma (HCC) is rising along with its mortality burden, and more than half of the patients require systemic therapy for advanced disease. There is an ongoing epid...
000
Emilie Gunn @emiliemgunn.bsky.social · 27/02/2025
📻 ICYMI: The second episode of the JCO Oncology Practice: Put Into Practice podcast is now live! Listen here and subscribe wherever you get your podcasts. ascopubs.org/do/optimizin... 🎙️
ascopubs.org
ASCO Publications
000
Emilie Gunn @emiliemgunn.bsky.social · 18/02/2025
Check out this infographic from #JCOCCI that accompanies the recent article, Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study. ascopubs.org/doi/10.1200/...
ascopubs.org
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study | JCO Clinical Cancer Informatics
PURPOSEWe evaluated the definitions of five comorbidities (renal and hepatic impairments, anemia, neutropenia, and thrombocytopenia) in women with breast cancer using data from electronic health recor...
000
Emilie Gunn @emiliemgunn.bsky.social · 05/02/2025
Let this be your soundtrack today, and Amazon Music will donate $1 for every stream to @conquercancer.bsky.social.
010
Reposted by Emilie Gunn
American Society of Clinical Oncology @ascocancer.bsky.social · 03/02/2025
We welcome Dr. Katherine Van Loon as our newest Editor-in-Chief of JCO Global Oncology. Welcome Dr. Van Loon!
081
Emilie Gunn @emiliemgunn.bsky.social · 24/01/2025
If you are at ASCO #GI25, you do NOT want to miss this session at 11:45 this morning, all about the process of publishing your research. Come hear from #JCO editors and network with others! @pamelakunzmd.bsky.social
010
Emilie Gunn @emiliemgunn.bsky.social · 23/01/2025
Attending ASCO #GI25? Stop by the ASCO booth and hear all about the JCO Oncology Advances, the newest member of the JCO Journals! Also learn more about the new podcast from #JCOOP.
041
Emilie Gunn @emiliemgunn.bsky.social · 21/01/2025
#JCOJournals are so excited about the launch of a new podcast from JCO Oncology Practice. This first episode, featuring host @fumikochino.bsky.social, is Debt or Dying: The JCO OP Financial Toxicity Special Issue. Don't miss it! ascopubs.org/do/debt-dyin...
150
Reposted by Emilie Gunn
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 11/01/2025
🚨 The #FinancialToxicity special issue of JCO OP is LIVE today! 🚨 We hope these papers will encourage the next gen of researchers to generate, evaluate, & disseminate patient-centered, high-quality, evidence-based medicine & policy solutions to close the affordability gap! ascopubs.org/toc/op/21/1
ascopubs.org
JCO Oncology Practice: Vol 21, No 1
12010
Reposted by Emilie Gunn
Jeremy Warner, MD, MS, FAMIA, FASCO @hemoncwarner.bsky.social · 06/01/2025
Can a machine learning (ML) algorithm outperform PD-L1 as a predictive biomarker for response to first-line therapy in patients with advanced non–small cell lung cancer? New #JCOCCI pub: ascopubs.org/doi/full/10.... @emiliemgunn.bsky.social @acochran12733.bsky.social
ascopubs.org
ASCO Publications
033
Emilie Gunn @emiliemgunn.bsky.social · 03/01/2025
🔔 ICYMI: Here are the top articles from JCO Journals from 2024: ascopubs.org/2024-top-art...
ascopubs.org
2024 Top Articles | ASCO Publications
032
Emilie Gunn @emiliemgunn.bsky.social · 02/01/2025
Oh man, I love a good pun. Especially with a publishing reference!
130
Reposted by Emilie Gunn
Jeremy Warner, MD, MS, FAMIA, FASCO @hemoncwarner.bsky.social · 09/12/2024
We have a new article in JCO CCI describing a symptom monitoring app that might help with endocrine therapy adherence; graphical abstract attached! #bcsm ascopubs.org/doi/full/10.... @acochran12733.bsky.social @drbeccak.bsky.social @emiliemgunn.bsky.social
Use of a remote monitoring app was similar across sociodemographic characteristics, and more frequent app use was associated with a higher likelihood of 6-month adjuvant endocrine therapy adherence for hormone receptor positive breast cancer. Encouraging women to monitor medication adherence and communicate adverse symptoms could improve adjuvant endocrine therapy adherence.
1103
Reposted by Emilie Gunn
Jeremy Warner, MD, MS, FAMIA, FASCO @hemoncwarner.bsky.social · 06/12/2024
New JCO CCI article: ascopubs.org/doi/full/10..... Jiang et al. used dynamic risk models to predict 5-year breast cancer risk in diverse populations. By using routinely collected interval imaging data, this modeling approach could enhance personalized screening strategies & early disease detection.
ascopubs.org
ASCO Publications
072
Reposted by Emilie Gunn
Jeremy Warner, MD, MS, FAMIA, FASCO @hemoncwarner.bsky.social · 02/12/2024
Automatic metastatic versus localized stage extraction from clinical trial publications just published in JCO CCI. Check it out today, and let us know your thoughts! ascopubs.org/doi/abs/10.1... @acochran12733.bsky.social @emiliemgunn.bsky.social
ascopubs.org
Metastatic Versus Localized Disease as Inclusion Criteria That Can Be Automatically Extracted From Randomized Controlled Trials Using Natural Language Processing | JCO Clinical Cancer Informatics
PURPOSEExtracting inclusion and exclusion criteria in a structured, automated fashion remains a challenge to developing better search functionalities or automating systematic reviews of randomized con...
0115